E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas (original) (raw)

• Babu M, Wells A (2001) Dermal-epidermal communication in wound healing. Wounds 13:183–189
  Google Scholar
• Birchmeier C, Birchmeier W, Gherardi E, VandeWoude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915–925
  Article PubMed CAS Google Scholar
• Boccaccio C, Comoglio PM (2006) Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6:637–645
  Article PubMed CAS Google Scholar
• Christiansen JJ, Rajasekaran AK (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66:8319–8326
  Article PubMed CAS Google Scholar
• Christofori G (2006) New signals from the invasive front. Nature 441:444–450
  Article PubMed CAS Google Scholar
• Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze’ev A (2003) Autoregulation of E-cadherin expression by cadherin–cadherin interactions: the roles of b-catenin signaling, Slug, and MAPK. J Cell Biol 163:847–857
  Article PubMed CAS Google Scholar
• Cristofanilli M, Budd GT et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791
  Article PubMed CAS Google Scholar
• Ewing J (1922) Tumors of the prostate. Neoplastic diseases. WB Saunders Company, Philadelphia, pp 784–785
• Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
  Article PubMed CAS Google Scholar
• Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374
  Article PubMed CAS Google Scholar
• Gleave ME, Hsieh JT, vonEschenbach AC, Chung LWK (1992) Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 147:1151–1159
  PubMed CAS Google Scholar
• Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG (2000) Methylation patterns of the E-cadherin 5’CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275:2727–2732
  Article PubMed CAS Google Scholar
• Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318
  Article PubMed CAS Google Scholar
• Gumbiner BM (2005) Regualtion of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622–634
  Article PubMed CAS Google Scholar
• Hazan RB, Norton L (1998) The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273:9078–9084
  Article PubMed CAS Google Scholar
• Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213:374–383
  Article PubMed CAS Google Scholar
• Imai T, Horiuchi A et al (2004) Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 35:1469–1476
  Article PubMed CAS Google Scholar
• Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428
  Article PubMed CAS Google Scholar
• Kaihara T, Kawamata H, Imura J, Fujii S, Kitajima K, Omotehara F, Maeda N, Nakamura T, Fujimori T (2003) Redifferentiation and ZO-1 reexpression in liver-metastatized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1. Cancer Sci 94:166–172
  Article PubMed CAS Google Scholar
• Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776–1784
  PubMed CAS Google Scholar
• Kang H-G, Jenabi JM et al (2007) E-cadherin cell–cell adhesion in Ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 67:3094–3105
  Article PubMed CAS Google Scholar
• Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279.
  Article PubMed CAS Google Scholar
• Kim H, Turner T, Kassis J, Souto J, Wells A (1999) EGF receptor signaling in prostate development. Histol Histopathol 14:1175–1182
  PubMed CAS Google Scholar
• Kopstein L, Christofori G (2006) Metastasis: cell autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63:449–468
  Article Google Scholar
• Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinoma of the breast and its distant metastases. Breast Cancer Res 5:R217–R222
  Article PubMed CAS Google Scholar
• Luzzi KJ, MacDonald IC et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873
  PubMed CAS Google Scholar
• Mamoune A, Kassis J et al (2004) DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Exp Cell Res 299:91–100
  Article PubMed CAS Google Scholar
• Miura H, Nishimura K et al (2001) Effects of hepatocyte growth factor on E-cadherin-mediated cell–cell adhesion in DU145 prostate cancer cells. Urology 58:1064–1069
  Article PubMed CAS Google Scholar
• Moustakas A, Heldin C-H (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512–1520
  Article PubMed CAS Google Scholar
• Nelson WJ, Nusse R (2004) Convergence of wnt, b-catenin, and cadherin pathways. Science 303:1483–1487
  Article PubMed CAS Google Scholar
• Paget S (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8:98–101
  PubMed CAS Google Scholar
• Putz E, Witter K et al (1999) Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res 59:241–248
  PubMed CAS Google Scholar
• Reddy P, Liu L et al (2005) Formation of E-cadherin mediated cell–cell adhesion activates Akt and mitogen activated protein kinase (MAPK) via phosphatidylinositol 3 kinase and ligand-independent action of epidermal growth factor (EGF) receptor in ovarian cancer cells. Mol Endocrinol 19:2564–2578
  Article PubMed CAS Google Scholar
• Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z (1994) Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol 14:8333–8342
  PubMed CAS Google Scholar
• Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML (2001) E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 32:690–697
  Article PubMed CAS Google Scholar
• Shah RB, Mehra R et al (2004) Androgen-independent prostate cancer is a heterogeneous group of diseases. Cancer Res 64:9209–9216
  Article PubMed CAS Google Scholar
• Shepard CR, Yates CC, Wells A (2007) Signaling pathway activation upon re-expression of E-cadherin in invasive breast cancer cells and interaction with ectopic normal epithelial cells (unpublished data)
• Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D, Ben-Ze’ev A (1996) Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J Cell Biol 133:199–209
  Article PubMed CAS Google Scholar
• Stessels F, VandenEynden G et al (2004) Breast adenocarcinoma liver metastases, in contrast to colorectal liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 90:1429–1436
  Article PubMed CAS Google Scholar
• Strathdee G (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin Seminars. Cancer Biol 12:373–379
  Google Scholar
• Tarin D (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65:5996–6000
  Article PubMed CAS Google Scholar
• Thompson EW, Newgreen DF (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition. Cancer Res 65:5991–5995
  Article PubMed CAS Google Scholar
• Wells A (2000) Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 78:31–101
  Article PubMed CAS Google Scholar
• Yates C, Shepard CR et al (2007a) Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res 96:225–246
  Article Google Scholar
• Yates C, Shepard CR, Stolz DB, Wells A (2007b) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96:1246–1252
  Article PubMed CAS Google Scholar
• Yates CC, Shepard CR, Stolz DB, Wells A (2007c) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96:1246–1252
  Article PubMed CAS Google Scholar
• Yates C, Wells A, Turner T (2005) Luteinizing hormone releasing hormone (LHRH) analog reverses the cell adhesion profile of DU-145 human prostate carcinoma. Br J Cancer 92:366–375
  PubMed CAS Google Scholar